Downregulation of SET-domain containing 5 (SETD5) significantly decreased breast cancer stem-like cells properties and glycolysis in vitro and in vivo.
[American Journal of Pathology]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Cancer Stem Cell News SETD5 Regulates Glycolysis in Breast Cancer Stem-Like Cells and Fuels Tumor Growth
